Before the results were released, RichardStein, a cardiologist at Beth-Israel Medical Center in New York argued that using these doses essentially stacked the deck against Zocor.
"I think most physicians think it is unethical to take a drug like that and market it with only one cholesterol-lowering medicine, " says RichardStein, a cardiologist at Beth Israel Medical Center.